Cytochrome P450 17A1 Inhibitor

This page covers all Cytochrome P450 17A1 Inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Steroid 17-alpha-hydroxylase/17,20 lyase.

Targets

Steroid 17-alpha-hydroxylase/17,20 lyase

Marketed (1)

• Zytiga · Johnson & Johnson · Oncology · 1500
  Zytiga blocks the production of male hormones that fuel prostate cancer growth.

Patent intelligence

• cytochrome p450 17a1 inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates